Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics

Direct-acting antivirals (DAAs) induce a rapid virologic response (SVR) in up to 99% of chronic hepatitis C patients. The role of SVR by DAAs on the incidence or recurrence of hepatocellular carcinoma (HCC) is still a matter of debate, although it is known that SVR does not eliminate the risk of HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Luca, Nevola, Riccardo, Franci, Gianluigi, Perrella, Alessandro, Corvino, Giusy, Marrone, Aldo, Berretta, Massimiliano, Morone, Maria Vittoria, Galdiero, Marilena, Giordano, Mauro, Adinolfi, Luigi Elio, Sasso, Ferdinando Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352473/
https://www.ncbi.nlm.nih.gov/pubmed/32466400
http://dx.doi.org/10.3390/cancers12061351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352473/
https://www.ncbi.nlm.nih.gov/pubmed/32466400
http://dx.doi.org/10.3390/cancers12061351

Ejemplares similares